Medicine
Volume 35, Issue 9 , Pages 503-506 , September 2007

Diabetic nephropathy

References 

  1. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–1462
  2. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–860
  3. Song JH, Cha SH, Lee HJ, et al. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-{beta} in type 2 diabetic patients with advanced kidney disease. Nephrol Dial Transplant. 2006;21:683–689
  4. Ruggenenti P, Fassi A, Ilieva AP, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351:1941–1951
  5. The Diabetes Control and Complications Research Group . Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47:1703–1720
  6. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependant Diabetes Mellitus. N Engl J Med. 1993;329:977–986
  7. The diabetes control and complications trial/epidemiology of diabetes intervention and complications research group . Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–389
  8. de Zeeuw D, Remuzzi G, Parving H-H, et al. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy. Circulation. 2004;110:921–927
  9. Atkins RC, Briganti EM, Lewis JB, et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005;45:281–287
  10. de Zeeuw D, Remuzzi G, Parving H-H, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL. Kidney Int. 2004;65:2309–2320
  11. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians of London and the Renal Association . Chronic kidney disease in adults: UK guidelines for identification, management and referral. London: Royal College of Physicians of London; 2006;Available at: www.renal.org/CKDguide/ckd.html
  12. National Service Frameworks for Diabetes and Renal Disease. Available at:www.dh.gov.uk and www.wales.nhs.uk
  13. National Kidney Foundation, Kidney Disease Outcomes Quality Initiative guidelines. Available at: www.kidney.org/Professionals/kdoqi/
  14. Feest T. Epidemiology and causes of chronic renal failure. Medicine. 2007;35:438–441

PII: S1357-3039(07)00180-6

doi: 10.1016/j.mpmed.2007.06.007

Medicine
Volume 35, Issue 9 , Pages 503-506 , September 2007

Article Tools

* Image Usage & Resolution